XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2

ACQUISITION–RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)

6 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Acquisition-related Restructuring and Discontinuation Costs

Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June 30, 2022 and 2021 summarized below (in thousands):

			Three Months Ended June 30,												Six Months Ended June 30,
			2022						2021						2022						2021
Severance-related expenses			$	950					$	—					$	4,065					$	—
Acquisition-related fees			2,168						7						4,013						7
Other acquisition expenses			104						—						552						—
Total acquisition-related charges			3,222						7						8,630						7
Flexion contingent consideration			(12,523)						—						(13,317)						—
MyoScience contingent consideration			(8,757)						139						(9,034)						(988)
Nuance Biotech Co. Ltd. agreement dissolution costs			—						—						—						3,000
Total acquisition-related (gains) charges, product discontinuation and other			$	(18,058)					$	146					$	(13,721)					$	2,019

X

- Definition

COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]

+ References

No definition available.

+ Details

Name:	pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock
Namespace Prefix:	pcrx_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration